A6-0255/2009 7.4.2009 REPORT on regulatory aspects of nanomaterials (2008/2208(INI)) Committee on the Environment, Public Health and Food Safety Rapporteur: Carl Schlyter PE 418.270v02-00 CONTENTS MOTION FOR A EUROPEAN PARLIAMENT RESOLUTION...............................................3 EXPLANATORY STATEMENT..............................................................................................15 OPINION OF THE COMMITTEE ON EMPLOYMENT AND SOCIAL AFFAIRS........... 19 RESULT OF FINAL VOTE IN COMMITTEE.........................................................................23 MOTION FOR A EUROPEAN PARLIAMENT RESOLUTION on regulatory aspects of nanomaterials ( 2008/2208(INI) ) The European Parliament , – having regard to the Commission Communication of 17 June 2008 entitled "Regulatory aspects of nanomaterials" ( COM(2008)0366 ) and the accompanying Commission staff working document ( SEC(2008)2036 ), – having regard to the Commission Communication of 12 May 2004 entitled "Towards a European strategy for nanotechnology" ( COM(2004)0338 ), – having regard to the Commission Communication of 7 June 2005 entitled "Nanosciences and nanotechnologies: An action plan for Europe 2005-2009" ( COM(2005)0243 ) ("the action plan") and to its resolution of 28 September 2006 OJ C 306 E, 15.12.2006, p. 426. on the action plan, – having regard to the Commission Communication "Nanosciences and nanotechnologies: An action plan for Europe 2005-2009. First Implementation Report 2005-2007" ( COM(2007)0505 ), – having regard to the opinions of the Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) on definitions and risk assessment of nanomaterials Opinion on "The scientific aspects of the existing and proposed definitions relating to products of nanoscience and nanotechnologies; 29 November 2007"; http://ec.europa.eu/health/ph_risk/committees/04_sc e nihr/docs/scenihr_o_012.pdf And accompanying Information by Commission services concerning the SCENIHR Opinion on Scientific Aspects of Existing and Proposed Definitions relating to Products of Nanoscience and Nanotechnologies; http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_oc_012.pdf Opinion on The Appropriateness of the Risk Assessment methodology in accordance with the technical guidance documents for new and existing substances for assessing the risks of nanomaterials; 21-22 June 2007; http://ec.europa.eu/health/p h _risk/committees/04_scenihr/docs/scenihr_o_010.pdf Modified opinion (after public consultation) on The appropriateness of existing methodologies to assess the potential risks associated with engineered and adventitious products of nanotechnologies; 10 March 2006; http://ec.europa.eu/healt h /ph_risk/com m ittees/04_scenihr/docs/scenihr_o_003b.pdf Opinion on Risk Assessment of Products of Nanotechnologies; 19 January 2009; http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_023.pdf , – having regard to the opinion of the Scientific Committee on Consumer Products (SCCP) on the safety of nanomaterials in cosmetics Opinion on Safety of nanomaterials in cosmetic products; 18 December 2007; http://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_123.pdf , – having regard to the Commission Recommendation on a code of conduct for responsible nanosciences and nanotechnologies research ( COM(2008)0424 ) ("Code of Conduct"), – having regard to the opinion from the European Group on Ethics in Science and New Technologies to the European Commission on the ethical aspects of nanomedicine Opinion No 21, 17 January 2007. , – having regard to Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) OJ L 396, 30.12.2006, p. 1. , – having regard to Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market OJ L 123, 24.4.1998, p. 1. , – having regard to Council Directive 89/391/EEC of 12 June 1989